Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) shares rose 16.7% on Monday . The company traded as high as GBX 20 ($0.25) and last traded at GBX 17.50 ($0.22). Approximately 27,811 shares changed hands during mid-day trading, a decline of 64% from the average daily volume of 77,314 shares. The stock had previously closed at GBX 15 ($0.19).
Celadon Pharmaceuticals Trading Up 14.3 %
The stock has a market capitalization of £13.77 million, a PE ratio of -250.00 and a beta of -0.26. The stock’s 50 day moving average price is GBX 21.48 and its 200-day moving average price is GBX 40.50. The company has a quick ratio of 6.97, a current ratio of 1.92 and a debt-to-equity ratio of 194.82.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Featured Stories
- Five stocks we like better than Celadon Pharmaceuticals
- What Are the FAANG Stocks and Are They Good Investments?
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What is the S&P 500 and How It is Distinct from Other Indexes
- 2 Drone Stocks Surging from Increased Media Attention
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
